|
US6207646B1
(en)
*
|
1994-07-15 |
2001-03-27 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
|
GB0121980D0
(en)
*
|
2001-09-11 |
2001-10-31 |
Cathnet Science Holding As |
Expandable stent
|
|
US7182779B2
(en)
|
2001-12-03 |
2007-02-27 |
Xtent, Inc. |
Apparatus and methods for positioning prostheses for deployment from a catheter
|
|
US7147656B2
(en)
|
2001-12-03 |
2006-12-12 |
Xtent, Inc. |
Apparatus and methods for delivery of braided prostheses
|
|
US7351255B2
(en)
|
2001-12-03 |
2008-04-01 |
Xtent, Inc. |
Stent delivery apparatus and method
|
|
US7892273B2
(en)
|
2001-12-03 |
2011-02-22 |
Xtent, Inc. |
Custom length stent apparatus
|
|
US7137993B2
(en)
|
2001-12-03 |
2006-11-21 |
Xtent, Inc. |
Apparatus and methods for delivery of multiple distributed stents
|
|
US20030135266A1
(en)
|
2001-12-03 |
2003-07-17 |
Xtent, Inc. |
Apparatus and methods for delivery of multiple distributed stents
|
|
US7309350B2
(en)
|
2001-12-03 |
2007-12-18 |
Xtent, Inc. |
Apparatus and methods for deployment of vascular prostheses
|
|
DE60335608D1
(de)
|
2002-02-27 |
2011-02-17 |
Pharmain Corp |
Zusammensetzungen zur abgabe von therapeutika und anderen materialien und verfahren zu ihrer herstellung und verwendung
|
|
US7635463B2
(en)
*
|
2002-02-27 |
2009-12-22 |
Pharmain Corporation |
Compositions for delivery of therapeutics and other materials
|
|
CN102144961A
(zh)
*
|
2003-09-18 |
2011-08-10 |
参天制药株式会社 |
经巩膜递送
|
|
US7326236B2
(en)
|
2003-12-23 |
2008-02-05 |
Xtent, Inc. |
Devices and methods for controlling and indicating the length of an interventional element
|
|
WO2005072710A2
(en)
*
|
2004-01-28 |
2005-08-11 |
Johns Hopkins University |
Drugs and gene carrier particles that rapidly move through mucous barriers
|
|
US8562505B2
(en)
|
2004-02-20 |
2013-10-22 |
The Children's Hospital Of Philadelphia |
Uniform field magnetization and targeting of therapeutic formulations
|
|
US7846201B2
(en)
*
|
2004-02-20 |
2010-12-07 |
The Children's Hospital Of Philadelphia |
Magnetically-driven biodegradable gene delivery nanoparticles formulated with surface-attached polycationic complex
|
|
US9028829B2
(en)
*
|
2004-02-20 |
2015-05-12 |
The Children's Hospital Of Philadelphia |
Uniform field magnetization and targeting of therapeutic formulations
|
|
US7323006B2
(en)
|
2004-03-30 |
2008-01-29 |
Xtent, Inc. |
Rapid exchange interventional devices and methods
|
|
US8317859B2
(en)
|
2004-06-28 |
2012-11-27 |
J.W. Medical Systems Ltd. |
Devices and methods for controlling expandable prostheses during deployment
|
|
US20050288766A1
(en)
*
|
2004-06-28 |
2005-12-29 |
Xtent, Inc. |
Devices and methods for controlling expandable prostheses during deployment
|
|
JP2008512350A
(ja)
*
|
2004-07-01 |
2008-04-24 |
イェール ユニバーシティ |
標的化され、そして高密度で薬物が負荷されるポリマー性物質
|
|
WO2006023207A2
(en)
*
|
2004-08-19 |
2006-03-02 |
The United States Of America As Represented By The Secretary Of Health And Human Services, Nih |
Coacervate of anionic and cationic polymer forming microparticles for the sustained release of therapeutic agents
|
|
ATE519451T1
(de)
*
|
2004-08-30 |
2011-08-15 |
Neville Alleyne |
Implantat zur behandlung von bändern und sehnen
|
|
EP1788986A1
(en)
*
|
2004-08-30 |
2007-05-30 |
Spineovations, Inc. |
Method of treating spinal internal disk derangement
|
|
US7985426B1
(en)
*
|
2004-10-05 |
2011-07-26 |
Hsing-Wen Sung |
Nanoparticles for targeting hepatoma cells and delivery means
|
|
US9492400B2
(en)
*
|
2004-11-04 |
2016-11-15 |
Massachusetts Institute Of Technology |
Coated controlled release polymer particles as efficient oral delivery vehicles for biopharmaceuticals
|
|
US8663639B2
(en)
*
|
2005-02-09 |
2014-03-04 |
Santen Pharmaceutical Co., Ltd. |
Formulations for treating ocular diseases and conditions
|
|
BRPI0607606B1
(pt)
|
2005-02-09 |
2021-06-22 |
Santen Pharmaceutical, Co., Ltd. |
Formulação líquida
|
|
US9205046B2
(en)
*
|
2005-04-25 |
2015-12-08 |
The Governing Council Of The University Of Toronto |
Enhanced stability of inverse thermal gelling composite hydrogels
|
|
US20070248675A1
(en)
*
|
2005-09-08 |
2007-10-25 |
Gwangju Institute Of Science And Technology |
Composite comprising polysaccharide-functionalized nanoparticle and hydrogel matrix, a drug delivery system and a bone defect replacement matrix for sustained release comprising the same, and the preparation method thereof
|
|
US8168584B2
(en)
|
2005-10-08 |
2012-05-01 |
Potentia Pharmaceuticals, Inc. |
Methods of treating age-related macular degeneration by compstatin and analogs thereof
|
|
US9267937B2
(en)
|
2005-12-15 |
2016-02-23 |
Massachusetts Institute Of Technology |
System for screening particles
|
|
CA2633070C
(en)
|
2005-12-19 |
2016-03-08 |
Pharmain Corporation |
Hydrophobic core carrier compositions for delivery of therapeutic agents, methods of making and using the same
|
|
BRPI0600285C1
(pt)
*
|
2006-01-13 |
2011-10-11 |
Brz Biotecnologia Ltda |
compostos farmacêuticos contendo nanopartìculas úteis para tratamento de lesões reestenóticas
|
|
CN101008643B
(zh)
*
|
2006-01-23 |
2013-03-27 |
中国人民解放军军事医学科学院生物医学分析中心 |
一种金属螯合纳米磁珠,其制备方法及应用
|
|
WO2007092620A2
(en)
|
2006-02-09 |
2007-08-16 |
Macusight, Inc. |
Stable formulations, and methods of their preparation and use
|
|
US8652198B2
(en)
|
2006-03-20 |
2014-02-18 |
J.W. Medical Systems Ltd. |
Apparatus and methods for deployment of linked prosthetic segments
|
|
JP5506378B2
(ja)
|
2006-03-23 |
2014-05-28 |
参天製薬株式会社 |
血管透過性に関連する疾患または病気のための製剤および方法
|
|
ES2776100T3
(es)
*
|
2006-03-31 |
2020-07-29 |
Massachusetts Inst Technology |
Sistema para el suministro dirigido de agentes terapéuticos
|
|
JP5282031B2
(ja)
*
|
2006-05-15 |
2013-09-04 |
ドミトリィ ビー カーポティン |
有機物を含む磁性微粒子
|
|
US8367113B2
(en)
|
2006-05-15 |
2013-02-05 |
Massachusetts Institute Of Technology |
Polymers for functional particles
|
|
US20110052697A1
(en)
*
|
2006-05-17 |
2011-03-03 |
Gwangju Institute Of Science & Technology |
Aptamer-Directed Drug Delivery
|
|
US20080069801A1
(en)
*
|
2006-06-13 |
2008-03-20 |
Lee Randall J |
Methods and apparatus for using polymer-based beads and hydrogels for cardiac applications
|
|
US9381477B2
(en)
|
2006-06-23 |
2016-07-05 |
Massachusetts Institute Of Technology |
Microfluidic synthesis of organic nanoparticles
|
|
US20100144845A1
(en)
*
|
2006-08-04 |
2010-06-10 |
Massachusetts Institute Of Technology |
Oligonucleotide systems for targeted intracellular delivery
|
|
ATE498393T1
(de)
*
|
2006-09-08 |
2011-03-15 |
Univ Johns Hopkins |
Zusammensetzungen zur transportintensivierung durch die schleimhaut
|
|
US8563022B2
(en)
*
|
2006-10-11 |
2013-10-22 |
Board Of Regents Of The University Of Texas System |
Particles for cell targeting
|
|
CA2668130A1
(en)
*
|
2006-11-03 |
2008-06-05 |
Boston Scientific Limited |
Stents with drug eluting coatings
|
|
US20080107744A1
(en)
*
|
2006-11-06 |
2008-05-08 |
Jack Fa-De Chu |
Injectable hollow tissue filler
|
|
US20110223664A1
(en)
*
|
2006-11-16 |
2011-09-15 |
The University Of Akron |
Materials and methods of introducing genetic material into living cells
|
|
US20100303723A1
(en)
*
|
2006-11-20 |
2010-12-02 |
Massachusetts Institute Of Technology |
Drug delivery systems using fc fragments
|
|
US8551139B2
(en)
|
2006-11-30 |
2013-10-08 |
Cook Medical Technologies Llc |
Visceral anchors for purse-string closure of perforations
|
|
US20080146489A1
(en)
*
|
2006-12-15 |
2008-06-19 |
Pacetti Stephen D |
Regional delivery of therapeutic agents for the treatment of vascular diseases
|
|
US7850382B2
(en)
*
|
2007-01-18 |
2010-12-14 |
Sanford, L.P. |
Valve made from two materials and writing utensil with retractable tip incorporating same
|
|
US7488130B2
(en)
|
2007-02-01 |
2009-02-10 |
Sanford, L.P. |
Seal assembly for retractable instrument
|
|
US9217129B2
(en)
*
|
2007-02-09 |
2015-12-22 |
Massachusetts Institute Of Technology |
Oscillating cell culture bioreactor
|
|
US8889117B2
(en)
*
|
2007-02-15 |
2014-11-18 |
Yale University |
Modular nanoparticles for adaptable vaccines
|
|
US10265407B2
(en)
|
2007-02-15 |
2019-04-23 |
Yale University |
Modular nanodevices for smart adaptable vaccines
|
|
US20080199510A1
(en)
|
2007-02-20 |
2008-08-21 |
Xtent, Inc. |
Thermo-mechanically controlled implants and methods of use
|
|
US20100151436A1
(en)
*
|
2007-03-02 |
2010-06-17 |
Fong Peter M |
Methods for Ex Vivo Administration of Drugs to Grafts Using Polymeric Nanoparticles
|
|
ES2525801T3
(es)
|
2007-03-07 |
2014-12-30 |
Uti Limited Partnership |
Composiciones y métodos para la prevención y el tratamiento de enfermedades autoinmunes
|
|
US8486132B2
(en)
|
2007-03-22 |
2013-07-16 |
J.W. Medical Systems Ltd. |
Devices and methods for controlling expandable prostheses during deployment
|
|
WO2008124634A1
(en)
|
2007-04-04 |
2008-10-16 |
Massachusetts Institute Of Technology |
Polymer-encapsulated reverse micelles
|
|
WO2008124639A2
(en)
*
|
2007-04-04 |
2008-10-16 |
Massachusetts Institute Of Technology |
Poly (amino acid) targeting moieties
|
|
CA2683777C
(en)
*
|
2007-04-13 |
2016-08-23 |
University Of North Texas Health Science Center At Fort Worth |
Formulation of active agent loaded activated plga nanoparticles for targeted cancer nano-therapeutics
|
|
US20100290982A1
(en)
*
|
2007-04-13 |
2010-11-18 |
University Of North Texas Health Science Center At Fort Worth |
Solid in oil/water emulsion-diffusion-evaporation formulation for preparing curcumin-loaded plga nanoparticles
|
|
US9044385B2
(en)
*
|
2007-05-16 |
2015-06-02 |
Abbott Cardiovascular Systems Inc. |
Therapeutic compositions for targeted vessel delivery
|
|
WO2008151005A2
(en)
*
|
2007-05-31 |
2008-12-11 |
Transtarget, Inc. |
Compositions and methods for tissue repair
|
|
EP2150183B1
(en)
*
|
2007-05-31 |
2013-03-20 |
Cook Medical Technologies LLC |
Suture lock
|
|
US20080299172A1
(en)
*
|
2007-06-04 |
2008-12-04 |
Stuart Young |
Tissue repair implant
|
|
US7901452B2
(en)
*
|
2007-06-27 |
2011-03-08 |
Abbott Cardiovascular Systems Inc. |
Method to fabricate a stent having selected morphology to reduce restenosis
|
|
DE102007030931A1
(de)
*
|
2007-07-03 |
2009-01-08 |
Birgit Riesinger |
Zusammensetzung, enthaltend mindestens einen nutritiven, mindestens einen desinfizierenden bzw. dekontaminierenden und/oder mindestens einen Proteasen hemmend wirkenden Wirkstoff und/oder Wirkstoffkomplex
|
|
WO2009010071A1
(en)
*
|
2007-07-16 |
2009-01-22 |
Aarhus Universitet |
Osteopontin nanoparticles system for drug delivery
|
|
WO2009015087A2
(en)
*
|
2007-07-20 |
2009-01-29 |
Potentia Pharmaceuticals, Inc. |
Compositions and methods for treatment of trauma
|
|
CN101888845B
(zh)
*
|
2007-07-23 |
2014-02-05 |
阿克伦大学 |
结合到生物可降解的纳米粒子的金属络合物及其应用
|
|
US7960336B2
(en)
|
2007-08-03 |
2011-06-14 |
Pharmain Corporation |
Composition for long-acting peptide analogs
|
|
US8563527B2
(en)
*
|
2007-08-20 |
2013-10-22 |
Pharmain Corporation |
Oligonucleotide core carrier compositions for delivery of nucleic acid-containing therapeutic agents, methods of making and using the same
|
|
US9173890B2
(en)
*
|
2007-09-20 |
2015-11-03 |
Abbott Cardiovascular Systems Inc. |
Sustained release of Apo A-I mimetic peptides and methods of treatment
|
|
EP2205161B1
(en)
*
|
2007-09-25 |
2016-11-30 |
Cook Medical Technologies LLC |
Medical devices, systems, and methods for using tissue anchors
|
|
HUE035101T2
(hu)
|
2007-09-28 |
2018-05-02 |
Pfizer |
Ráksejtek célzása nanorészecskék alkalmazásával
|
|
AU2008314647B2
(en)
*
|
2007-10-12 |
2013-03-21 |
Massachusetts Institute Of Technology |
Vaccine nanotechnology
|
|
WO2009050696A2
(en)
*
|
2007-10-18 |
2009-04-23 |
Qray Ltd. |
Composition and method for cell activation and tissue repair using nanoparticles and light
|
|
GB0721081D0
(en)
|
2007-10-26 |
2007-12-05 |
Metcalfe Susan M |
Immuno-modulatory composition
|
|
WO2009065077A1
(en)
*
|
2007-11-16 |
2009-05-22 |
Pharmain Corporation |
Cationic-core carrier compositions for delivery of therapeutic agents, methods of making and using the same
|
|
US20090157099A1
(en)
*
|
2007-12-18 |
2009-06-18 |
Wilson-Cook Medical, Inc. |
Device and method for placement of tissue anchors
|
|
US20090176892A1
(en)
*
|
2008-01-09 |
2009-07-09 |
Pharmain Corporation |
Soluble Hydrophobic Core Carrier Compositions for Delivery of Therapeutic Agents, Methods of Making and Using the Same
|
|
CA2713137C
(en)
|
2008-01-25 |
2017-10-24 |
Hadasit Medical Research Services And Development Ltd. |
Targeting of innate immune response to tumor site
|
|
US8469961B2
(en)
*
|
2008-03-05 |
2013-06-25 |
Neville Alleyne |
Methods and compositions for minimally invasive capsular augmentation of canine coxofemoral joints
|
|
US20100004700A1
(en)
*
|
2008-03-05 |
2010-01-07 |
Neville Alleyne |
Method of treating tissue with a suspenson of tricalcium hydroxyapatite microspheres
|
|
US9101503B2
(en)
|
2008-03-06 |
2015-08-11 |
J.W. Medical Systems Ltd. |
Apparatus having variable strut length and methods of use
|
|
US9241898B2
(en)
*
|
2008-03-11 |
2016-01-26 |
Yale University |
Compositions and methods for controlled delivery of inhibitory ribonucleic acids
|
|
US9822364B2
(en)
|
2008-03-11 |
2017-11-21 |
Yale University |
Compositions and methods for controlled delivery of inhibitory ribonucleic acids
|
|
US20110190221A1
(en)
*
|
2008-03-28 |
2011-08-04 |
Apellis Ag |
Modulation and repletion/enhancement of the complement system for treatment of trauma
|
|
US8226312B2
(en)
*
|
2008-03-28 |
2012-07-24 |
Sanford, L.P. |
Valve door having a force directing component and retractable instruments comprising same
|
|
WO2009137438A2
(en)
|
2008-05-06 |
2009-11-12 |
Wilson-Cook Medical Inc. |
Apparatus and methods for delivering therapeutic agents
|
|
US8697098B2
(en)
|
2011-02-25 |
2014-04-15 |
South Dakota State University |
Polymer conjugated protein micelles
|
|
US8728446B2
(en)
*
|
2008-06-03 |
2014-05-20 |
I Did It, Inc. |
Oral hygiene tablets and capsules for direct oral delivery of active ingredients
|
|
WO2010005725A2
(en)
|
2008-06-16 |
2010-01-14 |
Bind Biosciences, Inc. |
Therapeutic polymeric nanoparticles comprising vinca alkaloids and methods of making and using same
|
|
ES2765240T3
(es)
|
2008-06-16 |
2020-06-08 |
Pfizer |
Nanopartículas poliméricas cargadas de fármaco y procedimientos de fabricación y uso de las mismas
|
|
US8613951B2
(en)
*
|
2008-06-16 |
2013-12-24 |
Bind Therapeutics, Inc. |
Therapeutic polymeric nanoparticles with mTor inhibitors and methods of making and using same
|
|
US20110105417A1
(en)
*
|
2008-06-26 |
2011-05-05 |
The Curators Of The University Of Missouri |
Drug Conjugates
|
|
WO2010017215A2
(en)
*
|
2008-08-04 |
2010-02-11 |
The Regents Of The University Of California |
Biodegradable microspheres and methods of use thereof
|
|
US8591905B2
(en)
*
|
2008-10-12 |
2013-11-26 |
The Brigham And Women's Hospital, Inc. |
Nicotine immunonanotherapeutics
|
|
US8343497B2
(en)
*
|
2008-10-12 |
2013-01-01 |
The Brigham And Women's Hospital, Inc. |
Targeting of antigen presenting cells with immunonanotherapeutics
|
|
US8277812B2
(en)
|
2008-10-12 |
2012-10-02 |
Massachusetts Institute Of Technology |
Immunonanotherapeutics that provide IgG humoral response without T-cell antigen
|
|
US8343498B2
(en)
|
2008-10-12 |
2013-01-01 |
Massachusetts Institute Of Technology |
Adjuvant incorporation in immunonanotherapeutics
|
|
US8221012B2
(en)
*
|
2008-11-07 |
2012-07-17 |
Sanford, L.P. |
Retractable instruments comprising a one-piece valve door actuating assembly
|
|
EP2398466B1
(en)
*
|
2008-11-24 |
2021-02-17 |
Massachusetts Institute of Technology |
Methods and compositions for localized nanoparticle delivery to a tumor
|
|
US8377095B2
(en)
*
|
2008-12-05 |
2013-02-19 |
Cook Medical Technologies, LLC |
Tissue anchors for purse-string closure of perforations
|
|
US8563041B2
(en)
|
2008-12-12 |
2013-10-22 |
Bind Therapeutics, Inc. |
Therapeutic particles suitable for parenteral administration and methods of making and using same
|
|
US20100216804A1
(en)
*
|
2008-12-15 |
2010-08-26 |
Zale Stephen E |
Long Circulating Nanoparticles for Sustained Release of Therapeutic Agents
|
|
WO2010074949A1
(en)
*
|
2008-12-23 |
2010-07-01 |
Wilson-Cook Medical Inc. |
Apparatus and methods for containing and delivering therapeutic agents
|
|
US8393814B2
(en)
|
2009-01-30 |
2013-03-12 |
Sanford, L.P. |
Retractable instrument having a two stage protraction/retraction sequence
|
|
CA2750242C
(en)
|
2009-02-12 |
2018-05-22 |
Incept, Llc |
Drug delivery through hydrogel plugs
|
|
WO2010114768A1
(en)
*
|
2009-03-30 |
2010-10-07 |
Cerulean Pharma Inc. |
Polymer-epothilone conjugates, particles, compositions, and related methods of use
|
|
WO2010114770A1
(en)
*
|
2009-03-30 |
2010-10-07 |
Cerulean Pharma Inc. |
Polymer-agent conjugates, particles, compositions, and related methods of use
|
|
WO2010117668A1
(en)
*
|
2009-03-30 |
2010-10-14 |
Cerulean Pharma Inc. |
Polymer-agent conjugates, particles, compositions, and related methods of use
|
|
FR2943544B1
(fr)
*
|
2009-03-31 |
2012-04-20 |
Univ Angers |
Procede de preparation de capsules lipidiques fonctionnalisees.
|
|
JP5619138B2
(ja)
*
|
2009-04-03 |
2014-11-05 |
クック メディカル テクノロジーズ エルエルシーＣｏｏｋ Ｍｅｄｉｃａｌ Ｔｅｃｈｎｏｌｏｇｉｅｓ Ｌｌｃ |
組織アンカーの迅速な配備と固定のための医療デバイス、システム、及び方法
|
|
JP5619137B2
(ja)
|
2009-04-03 |
2014-11-05 |
クック メディカル テクノロジーズ エルエルシーＣｏｏｋ Ｍｅｄｉｃａｌ Ｔｅｃｈｎｏｌｏｇｉｅｓ Ｌｌｃ |
組織アンカー、及び組織アンカーの迅速な配備のための医療デバイス
|
|
US20100260850A1
(en)
*
|
2009-04-08 |
2010-10-14 |
Surmodics, Inc. |
Controlled Release Devices and Methods for Delivery of Nucleic Acids
|
|
KR20120022984A
(ko)
*
|
2009-04-21 |
2012-03-12 |
셀렉타 바이오사이언시즈, 인크. |
Ｔｈ１ 편향 반응을 제공하는 면역나노치료법
|
|
GB2470378A
(en)
*
|
2009-05-20 |
2010-11-24 |
Univ Westminster |
A controlled release composition for intraocular delivery of a therapeutic agent
|
|
MX357630B
(es)
|
2009-05-27 |
2018-07-17 |
Selecta Biosciences Inc |
Nanoportadores sintéticos objetivo con liberación sensible al ph de agentes inmunomoduladores.
|
|
US8118777B2
(en)
|
2009-05-29 |
2012-02-21 |
Cook Medical Technologies Llc |
Systems and methods for delivering therapeutic agents
|
|
US9101744B2
(en)
|
2009-05-29 |
2015-08-11 |
Cook Medical Technologies Llc |
Systems and methods for delivering therapeutic agents
|
|
US20100324124A1
(en)
*
|
2009-06-17 |
2010-12-23 |
Massachusetts Institute Of Technology |
Compositions and methods relating to DNA-based particles
|
|
AU2010293059B2
(en)
|
2009-08-26 |
2017-03-16 |
Selecta Biosciences, Inc. |
Compositions that induce T cell help
|
|
US20110091560A1
(en)
*
|
2009-10-21 |
2011-04-21 |
The Burnham Institute For Medical Research |
Compositions of nanoparticles and methods of making the same
|
|
US8808724B2
(en)
*
|
2009-10-28 |
2014-08-19 |
Ethicon, Inc. |
Antimicrobial coatings with preferred microstructure for medical devices
|
|
JP5891175B2
(ja)
|
2009-12-11 |
2016-03-22 |
バインド セラピューティックス インコーポレイテッド |
治療用粒子の凍結乾燥に対する安定製剤
|
|
US9439941B2
(en)
*
|
2009-12-14 |
2016-09-13 |
The University Of Hong Kong |
Nano cancer barrier device (NCBD) to immobilize and inhibit the division of metastic cancer stem cells
|
|
EP2515942B1
(en)
|
2009-12-15 |
2020-02-12 |
Pfizer Inc. |
Therapeutic polymeric nanoparticle compositions with high glass transition temperature or high molecular weight copolymers
|
|
GB0922066D0
(en)
|
2009-12-17 |
2010-02-03 |
Univ Belfast |
Modulator
|
|
EP2538929A4
(en)
|
2010-02-25 |
2014-07-09 |
Univ Johns Hopkins |
DELAYED RELEASE OF THERAPIES IN A PART OF THE EYE
|
|
US8747869B2
(en)
*
|
2010-03-19 |
2014-06-10 |
Massachusetts Institute Of Technology |
Lipid vesicle compositions and methods of use
|
|
US9149432B2
(en)
|
2010-03-19 |
2015-10-06 |
Massachusetts Institute Of Technology |
Lipid vesicle compositions and methods of use
|
|
US20110229556A1
(en)
*
|
2010-03-19 |
2011-09-22 |
Massachusetts Institute Of Technology |
Lipid-coated polymer particles for immune stimulation
|
|
EA030813B1
(ru)
|
2010-05-26 |
2018-10-31 |
Селекта Байосайенсиз, Инк |
Способы генерации антительного иммунного ответа и увеличения местной индукции иммунных цитокинов при использовании синтетических наноносителей, соединенных с адъювантами
|
|
WO2011163394A2
(en)
|
2010-06-22 |
2011-12-29 |
Apellis Pharmaceuticals, Inc. |
Compstatin analogs for treatment of neuropathic pain
|
|
US8865123B1
(en)
|
2010-09-16 |
2014-10-21 |
Mo-Sci Corporation |
Strontium phosphate microparticle for radiological imaging and therapy
|
|
US9849200B2
(en)
|
2010-09-16 |
2017-12-26 |
Mo-Sci Corporation |
Strontium phosphate microparticle for radiological imaging and therapy
|
|
US9119887B2
(en)
|
2010-09-16 |
2015-09-01 |
Mo-Sci Corporation |
Low-density magnesium-aluminum-silicate (MAS) microparticles for radiotherapy and/or radioimaging
|
|
US9744235B2
(en)
|
2010-10-19 |
2017-08-29 |
The Board Of Regents Of The University Of Oklahoma |
Treatment of cardiovascular disorders with targeted nanoparticles
|
|
US8740872B2
(en)
|
2010-10-19 |
2014-06-03 |
The Board Of Regents Of The University Of Oklahoma |
Magnetically-targeted treatment for cardiac disorders
|
|
US10398668B2
(en)
|
2010-10-19 |
2019-09-03 |
The Board Of Regents Of The University Of Oklahoma |
Glutamate treatment of cardiovascular disorders
|
|
US10016371B2
(en)
|
2010-10-22 |
2018-07-10 |
University Of Florida Research Foundation |
Antigen-specific, tolerance-inducing microparticles and uses thereof
|
|
US9994443B2
(en)
|
2010-11-05 |
2018-06-12 |
Selecta Biosciences, Inc. |
Modified nicotinic compounds and related methods
|
|
US9511151B2
(en)
|
2010-11-12 |
2016-12-06 |
Uti Limited Partnership |
Compositions and methods for the prevention and treatment of cancer
|
|
JP6035633B2
(ja)
|
2010-12-02 |
2016-11-30 |
グリーンマーク バイオメディカル インコーポレイテッドＧｒｅｅｎＭａｒｋ Ｂｉｏｍｅｄｉｃａｌ， Ｉｎｃ． |
アプタマーバイオコンジュゲート薬物送達システム
|
|
WO2013081720A1
(en)
*
|
2011-12-02 |
2013-06-06 |
Ecosynthetix Ltd. |
Aptamer bioconjugate drug delivery device
|
|
WO2012078968A2
(en)
|
2010-12-10 |
2012-06-14 |
Lifeline Scientific, Inc. |
Machine perfusion with complement inhibitors
|
|
US9327037B2
(en)
|
2011-02-08 |
2016-05-03 |
The Johns Hopkins University |
Mucus penetrating gene carriers
|
|
EP2678007A4
(en)
|
2011-02-25 |
2015-08-12 |
Univ South Dakota |
PROTEIN NANOTRIER FOR TOPICAL ADMINISTRATION
|
|
CA2828253C
(en)
|
2011-02-25 |
2016-10-18 |
South Dakota State University |
Polymer conjugated protein micelles
|
|
MX2013012596A
(es)
|
2011-04-29 |
2014-08-21 |
Selecta Biosciences Inc |
Nanoportadores sintéticos tolerogénicos para generar linfocitos t reguladores cd8+.
|
|
WO2013019648A1
(en)
|
2011-07-29 |
2013-02-07 |
Selecta Biosciences, Inc. |
Control of antibody responses to synthetic nanocarriers
|
|
US10226417B2
(en)
|
2011-09-16 |
2019-03-12 |
Peter Jarrett |
Drug delivery systems and applications
|
|
US9381112B1
(en)
|
2011-10-06 |
2016-07-05 |
William Eric Sponsell |
Bleb drainage device, ophthalmological product and methods
|
|
WO2013082503A1
(en)
*
|
2011-12-01 |
2013-06-06 |
Flow Pharma, Inc. |
Peptide particle formulation
|
|
US8632489B1
(en)
|
2011-12-22 |
2014-01-21 |
A. Mateen Ahmed |
Implantable medical assembly and methods
|
|
US10159743B2
(en)
|
2012-03-16 |
2018-12-25 |
The Johns Hopkins University |
Non-linear multiblock copolymer-drug conjugates for the delivery of active agents
|
|
CA2867381C
(en)
|
2012-03-16 |
2016-09-20 |
The Johns Hopkins University |
Controlled release formulations for the delivery of hif-1 inhibitors
|
|
US10988516B2
(en)
|
2012-03-26 |
2021-04-27 |
Uti Limited Partnership |
Methods and compositions for treating inflammation
|
|
US9597385B2
(en)
|
2012-04-23 |
2017-03-21 |
Allertein Therapeutics, Llc |
Nanoparticles for treatment of allergy
|
|
EP2844227B1
(en)
|
2012-05-03 |
2020-11-18 |
Kala Pharmaceuticals, Inc. |
Pharmaceutical nanoparticles showing improved mucosal transport
|
|
US9827191B2
(en)
|
2012-05-03 |
2017-11-28 |
The Johns Hopkins University |
Compositions and methods for ophthalmic and/or other applications
|
|
US11596599B2
(en)
|
2012-05-03 |
2023-03-07 |
The Johns Hopkins University |
Compositions and methods for ophthalmic and/or other applications
|
|
EP4008355A1
(en)
|
2012-05-03 |
2022-06-08 |
Kala Pharmaceuticals, Inc. |
Pharmaceutical nanoparticles showing improved mucosal transport
|
|
US9533068B2
(en)
|
2012-05-04 |
2017-01-03 |
The Johns Hopkins University |
Drug loaded microfiber sutures for ophthalmic application
|
|
JP6557140B2
(ja)
|
2012-06-21 |
2019-08-07 |
ノースウェスタン ユニバーシティ |
ペプチドコンジュゲート粒子
|
|
EP2887954B1
(en)
|
2012-08-23 |
2020-05-06 |
Susan Marie Metcalfe |
Neurotherapeutic nanoparticle compositions
|
|
CA2885193C
(en)
|
2012-09-17 |
2021-04-27 |
Bind Therapeutics, Inc. |
Process for preparing therapeutic nanoparticles
|
|
US9603948B2
(en)
|
2012-10-11 |
2017-03-28 |
Uti Limited Partnership |
Methods and compositions for treating multiple sclerosis and related disorders
|
|
EP2914247A4
(en)
*
|
2012-10-30 |
2016-06-29 |
Particle Sciences Inc |
DRUG DELIVERY PARTICLE FORMULATIONS WITH TARGETING ELEMENTS
|
|
WO2014074952A1
(en)
|
2012-11-09 |
2014-05-15 |
Massachusetts Institute Of Technology |
Methods and compositions for localized delivery of agents to hiv-infected cells and tissues
|
|
ES2879430T3
(es)
|
2012-11-15 |
2021-11-22 |
Apellis Pharmaceuticals Inc |
Análogos de compstatina de acción prolongada y composiciones y métodos relacionados
|
|
US10568975B2
(en)
|
2013-02-05 |
2020-02-25 |
The Johns Hopkins University |
Nanoparticles for magnetic resonance imaging tracking and methods of making and using thereof
|
|
JP6669499B2
(ja)
|
2013-02-15 |
2020-03-18 |
カラ ファーマシューティカルズ インコーポレイテッド |
治療用化合物
|
|
US9688688B2
(en)
|
2013-02-20 |
2017-06-27 |
Kala Pharmaceuticals, Inc. |
Crystalline forms of 4-((4-((4-fluoro-2-methyl-1H-indol-5-yl)oxy)-6-methoxyquinazolin-7-yl)oxy)-1-(2-oxa-7-azaspiro[3.5]nonan-7-yl)butan-1-one and uses thereof
|
|
CA2900680C
(en)
|
2013-02-20 |
2021-08-10 |
Kala Pharmaceuticals, Inc. |
Quinoline and quinazoline compounds and uses thereof for treating and/or preventing diseases
|
|
WO2014160465A2
(en)
|
2013-03-13 |
2014-10-02 |
Cour Pharmaceuticals Development Company |
Immune-modifying particles for the treatment of inflammation
|
|
EP3575397A1
(en)
|
2013-03-14 |
2019-12-04 |
Ran Biotechnologies, Inc. |
Methods and materials for microorganism capture
|
|
KR102352614B1
(ko)
|
2013-03-14 |
2022-01-18 |
랜 바이오테크놀러지스, 인크. |
생물제제의 검출을 위한 방법 및 물질
|
|
US9867931B2
(en)
|
2013-10-02 |
2018-01-16 |
Cook Medical Technologies Llc |
Therapeutic agents for delivery using a catheter and pressure source
|
|
US10308687B2
(en)
|
2013-03-15 |
2019-06-04 |
Apellis Pharmaceuticals, Inc. |
Cell-penetrating compstatin analogs and uses thereof
|
|
WO2014145205A2
(en)
|
2013-03-15 |
2014-09-18 |
St. Jude Children's Research Hospital |
Methods and compositions of p27kip1 transcription modulators
|
|
US11931227B2
(en)
|
2013-03-15 |
2024-03-19 |
Cook Medical Technologies Llc |
Bimodal treatment methods and compositions for gastrointestinal lesions with active bleeding
|
|
US10363227B2
(en)
*
|
2013-03-27 |
2019-07-30 |
Centre Hospitalier Universitaire Vaudois |
Pharmaceutical formulation for use in the treatment and/or prevention of restenosis
|
|
MX375502B
(es)
|
2013-04-03 |
2025-03-04 |
N Fold Llc |
Composiciones de nanoparticulas novedosas.
|
|
US10994013B2
(en)
|
2013-04-24 |
2021-05-04 |
Temple University—Of the Commonwealth System of Higher Education |
Solid dosage form containing arabinogalactan
|
|
BR112015027279A8
(pt)
|
2013-05-03 |
2018-01-30 |
Selecta Biosciences Inc |
métodos e composições para acentuar células t reguladoras cd4+
|
|
AU2014262164B2
(en)
*
|
2013-05-03 |
2020-02-27 |
Selecta Biosciences, Inc. |
Dosing combinations for reducing undesired humoral immune responses
|
|
WO2014186435A2
(en)
|
2013-05-14 |
2014-11-20 |
University Of Georgia Research Foundation, Inc. |
Compositions and methods for reducing neointima formation
|
|
AU2014274894A1
(en)
|
2013-06-04 |
2015-11-26 |
Selecta Biosciences, Inc. |
Repeated administration of non-immunosupressive antigen specific immunotherapeutics
|
|
CA2953287A1
(en)
|
2013-06-19 |
2014-12-24 |
Massachusetts Institute Of Technology |
In vivo targeting of cells with ligand-conjugated particles
|
|
BR112016003084A2
(pt)
|
2013-08-13 |
2017-09-12 |
Univ Northwestern |
partículas conjugadas com peptídeo
|
|
DK3035974T3
(da)
|
2013-08-22 |
2020-01-02 |
Arch Biosurgery Inc |
Implanterbare net til styring af bevægelsen af fluider
|
|
ES2904276T3
(es)
|
2013-09-27 |
2022-04-04 |
Massachusetts Inst Technology |
Nanoestructuras de proteínas biológicamente activas sin vehículo
|
|
AU2014324535B2
(en)
|
2013-09-29 |
2017-03-30 |
St. Jude Children's Research Hospital, Inc. |
Aryl substituted aminomethyl spectinomycin analogs as antibacterial agents
|
|
US20170080093A1
(en)
*
|
2013-10-22 |
2017-03-23 |
Tyme, Inc. |
Tyrosine Derivatives And Compositions Comprising Them
|
|
US9585841B2
(en)
*
|
2013-10-22 |
2017-03-07 |
Tyme, Inc. |
Tyrosine derivatives and compositions comprising them
|
|
US9890173B2
(en)
|
2013-11-01 |
2018-02-13 |
Kala Pharmaceuticals, Inc. |
Crystalline forms of therapeutic compounds and uses thereof
|
|
CN110302162A
(zh)
*
|
2013-11-01 |
2019-10-08 |
耶鲁大学 |
用于免疫疗法的模块化粒子
|
|
AU2014342042B2
(en)
|
2013-11-01 |
2017-08-17 |
KALA BIO, Inc. |
Crystalline forms of therapeutic compounds and uses thereof
|
|
SG10201912301XA
(en)
|
2013-11-04 |
2020-02-27 |
Uti Lp |
Methods and compositions for sustained immunotherapy
|
|
US20170000899A1
(en)
*
|
2013-11-26 |
2017-01-05 |
The Brigham And Women's Hospital, Inc. |
Receptor-targeted nanoparticles for enhanced transcytosis mediated drug delivery
|
|
ES2834927T3
(es)
|
2014-03-14 |
2021-06-21 |
Pfizer |
Nanopartículas terapéuticas que comprenden un agente terapéutico y procedimientos de fabricación y uso de las mismas
|
|
KR102492647B1
(ko)
|
2014-05-02 |
2023-01-30 |
더 리서치 인스티튜트 앳 네이션와이드 칠드런스 하스피탈 |
항-ｌｙｓｔ 면역조절을 위한 조성물 및 방법
|
|
WO2015172153A1
(en)
|
2014-05-09 |
2015-11-12 |
Yale University |
Topical formulation of hyperbranched polyglycerol-coated particles thereof
|
|
US11918695B2
(en)
|
2014-05-09 |
2024-03-05 |
Yale University |
Topical formulation of hyperbranched polymer-coated particles
|
|
US10898593B2
(en)
*
|
2014-05-13 |
2021-01-26 |
Yale University |
Compositions for nanoconfinement induced contrast enhancement and methods of making and using thereof
|
|
EP3154694B1
(en)
|
2014-06-13 |
2025-01-29 |
Children's Medical Center Corporation |
Products and methods to isolate mitochondria
|
|
WO2015200728A1
(en)
|
2014-06-25 |
2015-12-30 |
Selecta Biosciences, Inc. |
Methods and compositions for treatment with synthetic nanocarriers and immune checkpoint inhibitors
|
|
US20160074532A1
(en)
|
2014-09-07 |
2016-03-17 |
Selecta Biosciences, Inc. |
Methods and compositions for attenuating gene editing anti-viral transfer vector immune responses
|
|
US11633355B2
(en)
|
2014-12-12 |
2023-04-25 |
Clemson University Research Foundation |
Multi-functional particles and methods of using the same
|
|
US10232050B1
(en)
|
2014-12-12 |
2019-03-19 |
Clemson University |
Multi-functional particles and methods of using the same
|
|
SG10201906601TA
(en)
|
2015-01-16 |
2019-09-27 |
Spineovations Inc |
Method of treating spinal disk
|
|
KR20170106460A
(ko)
|
2015-01-27 |
2017-09-20 |
더 존스 홉킨스 유니버시티 |
점막표면에서 활성제의 향상된 수송을 위한 저장성 하이드로겔 제제
|
|
WO2016172183A1
(en)
|
2015-04-21 |
2016-10-27 |
Ran Biotechnologies, Inc. |
Novel fluorinated surfactants
|
|
HK1252348A1
(zh)
|
2015-05-06 |
2019-05-24 |
Uti Limited Partnership |
用於持续疗法的纳米颗粒组合物
|
|
US10385311B2
(en)
*
|
2015-05-27 |
2019-08-20 |
Purdue Research Foundation |
Method of making biological tissue components
|
|
JP6902025B2
(ja)
|
2015-06-18 |
2021-07-14 |
ティン セラピューティックス エルエルシー |
聴覚損失の予防および治療のための方法および組成物
|
|
WO2017027843A1
(en)
|
2015-08-12 |
2017-02-16 |
Massachusetts Institute Of Technology |
Cell surface coupling of nanoparticles
|
|
DK3359555T3
(da)
|
2015-10-07 |
2024-03-25 |
Apellis Pharmaceuticals Inc |
Doseringsplaner
|
|
CN105363071B
(zh)
*
|
2015-11-23 |
2018-10-09 |
金仕生物科技（常熟）有限公司 |
生物材料的抗钙化处理方法
|
|
EP3383411B1
(en)
|
2015-11-30 |
2025-07-09 |
Sana Biotechnology, Inc. |
Sub-mitochondrial particles for use in treating metabolic conditions
|
|
WO2017096262A1
(en)
|
2015-12-04 |
2017-06-08 |
Jomoco, Corp. |
Compositions and methods to mitigate or prevent an immune response to an immunogenic therapeutic molecule in non-human primates
|
|
EP3389720A1
(en)
|
2015-12-18 |
2018-10-24 |
The General Hospital Corporation |
Polyacetal polymers, conjugates, particles and uses thereof
|
|
JP7185527B2
(ja)
|
2016-01-15 |
2022-12-07 |
ザ チルドレンズ メディカル センター コーポレーション |
ミトコンドリアおよび組み合わされたミトコンドリア剤の治療的使用
|
|
AU2017221424A1
(en)
|
2016-02-16 |
2018-09-20 |
Yale University |
Compositions and methods for treatment of cystic fibrosis
|
|
EP3416976A2
(en)
|
2016-02-16 |
2018-12-26 |
Yale University |
Compositions for enhancing targeted gene editing and methods of use thereof
|
|
DK3426285T3
(da)
|
2016-03-11 |
2024-08-26 |
Cartesian Therapeutics Inc |
Formuleringer og doser af pegyleret uricase
|
|
US20200289666A1
(en)
*
|
2016-03-28 |
2020-09-17 |
The Johns Hopkins University |
Biomimetic anisotropic polymeric particles with naturally derived cell membranes for enhanced drug delivery
|
|
PL3436012T3
(pl)
*
|
2016-03-30 |
2024-04-08 |
Convatec Technologies Inc. |
Zmodyfikowany opatrunek do ran
|
|
CN116077439A
(zh)
|
2016-04-29 |
2023-05-09 |
西奈山伊坎医学院 |
靶向先天免疫系统以诱导长期耐受性及解决动脉粥样硬化中的巨噬细胞累积
|
|
EP3468581A1
(en)
|
2016-06-13 |
2019-04-17 |
Torque Therapeutics, Inc. |
Methods and compositions for promoting immune cell function
|
|
CA3036340A1
(en)
|
2016-09-08 |
2018-03-15 |
Kala Pharmaceuticals, Inc. |
Crystalline forms of therapeutic compounds and uses thereof
|
|
AU2017324713B2
(en)
|
2016-09-08 |
2020-08-13 |
KALA BIO, Inc. |
Crystalline forms of therapeutic compounds and uses thereof
|
|
CA3036065A1
(en)
|
2016-09-08 |
2018-03-15 |
Kala Pharmaceuticals, Inc. |
Crystalline forms of therapeutic compounds and uses thereof
|
|
WO2018064215A1
(en)
|
2016-09-27 |
2018-04-05 |
Selecta Biosciences, Inc. |
Recombinant immunotoxins for use in the treatment of cancer
|
|
WO2018089688A1
(en)
|
2016-11-09 |
2018-05-17 |
Jinjun Shi |
Restoration of tumor suppression using mrna-based delivery system
|
|
US11559606B2
(en)
|
2016-12-09 |
2023-01-24 |
The Penn State Research Foundation |
Semi-synthetic tissue constructs for tissue regeneration
|
|
JP2020506890A
(ja)
|
2017-01-07 |
2020-03-05 |
セレクタ バイオサイエンシーズ インコーポレーテッドＳｅｌｅｃｔａ Ｂｉｏｓｃｉｅｎｃｅｓ，Ｉｎｃ． |
合成ナノキャリアにカップリングした免疫抑制剤のパターン化された投与
|
|
EP3592389B1
(en)
|
2017-03-11 |
2025-05-07 |
Cartesian Therapeutics, Inc. |
Methods and compositions related to combined treatment with anti-inflammatories and synthetic nanocarriers comprising an immunosuppressant
|
|
US20200113821A1
(en)
|
2017-04-04 |
2020-04-16 |
Yale University |
Compositions and methods for in utero delivery
|
|
IL314891B1
(en)
|
2017-04-07 |
2025-11-01 |
Apellis Pharmaceuticals Inc |
Dosing regimens and related compositions and methods
|
|
KR102761577B1
(ko)
|
2017-05-08 |
2025-02-03 |
플래그쉽 파이어니어링 이노베이션스 브이, 인크. |
막 융합을 촉진시키기 위한 조성물 및 그의 용도
|
|
EP3630171A1
(en)
|
2017-05-26 |
2020-04-08 |
Animal Microbiome Analytics, Inc. |
Products and methods for therapeutic administration of microorganisms to non-human animals
|
|
CA3066750A1
(en)
|
2017-06-13 |
2018-12-20 |
Flagship Pioneering Innovations V, Inc. |
Compositions comprising curons and uses thereof
|
|
US20180355121A1
(en)
*
|
2017-06-13 |
2018-12-13 |
Uvic Industry Partnerships Inc. |
Multifunctional microcarriers with thermo-responsive biomaterial coating and use thereof
|
|
KR20210032924A
(ko)
|
2017-09-05 |
2021-03-25 |
토크 테라퓨틱스, 인코포레이티드 |
치료용 단백질 조성물 및 그의 제조 및 사용 방법
|
|
KR20200086670A
(ko)
|
2017-10-13 |
2020-07-17 |
셀렉타 바이오사이언시즈, 인크. |
항바이러스 전달 벡터 IgM 반응을 약화시키기 위한 방법 및 조성물
|
|
JP7436372B2
(ja)
|
2017-11-29 |
2024-02-21 |
ユーティアイ・リミテッド・パートナーシップ |
自己免疫性疾患を治療する方法
|
|
AU2018386304B2
(en)
|
2017-12-15 |
2023-12-07 |
Apellis Pharmaceuticals, Inc. |
Dosing regimens and related compositions and methods
|
|
CN108175864A
(zh)
*
|
2018-01-12 |
2018-06-19 |
中山大学 |
一种多模态成像纳米探针及其合成方法
|
|
CA3090303A1
(en)
|
2018-03-28 |
2019-10-03 |
Greenmark Biomedical Inc. |
Phosphate crosslinked starch nanoparticle and dental treatments
|
|
AU2019275409B2
(en)
|
2018-05-24 |
2024-08-15 |
Celanese Eva Performance Polymers Llc |
Implantable device for sustained release of a macromolecular drug compound
|
|
WO2019222856A1
(en)
|
2018-05-24 |
2019-11-28 |
Nureva Inc. |
Method, apparatus and computer-readable media to manage semi-constant (persistent) sound sources in microphone pickup/focus zones
|
|
JP2021524841A
(ja)
|
2018-05-24 |
2021-09-16 |
セラニーズ・イーブイエイ・パフォーマンス・ポリマーズ・エルエルシー |
高分子薬剤化合物の持続放出用の埋め込み型デバイス
|
|
CN112771070A
(zh)
|
2018-07-16 |
2021-05-07 |
西莱克塔生物科技公司 |
Otc构建体和载体的方法和组合物
|
|
MX2021000638A
(es)
|
2018-07-16 |
2021-06-23 |
Selecta Biosciences Inc |
Métodos y composiciones de construcciones y vectores de acidemia metilmalónica.
|
|
WO2020033951A1
(en)
|
2018-08-10 |
2020-02-13 |
Yale University |
Compositions and methods for embryonic gene editing in vitro
|
|
CN110836966A
(zh)
*
|
2018-08-15 |
2020-02-25 |
王镕 |
用于抗原特异性t细胞含量检测的检测纳米颗粒、检测方法及试剂盒等
|
|
WO2020146031A1
(en)
*
|
2018-10-18 |
2020-07-16 |
The Regents Of The University Of California |
Methods for fabricating modular hydrogels from macromolecules with orthogonal physico-chemical responsivity
|
|
US11166996B2
(en)
|
2018-12-12 |
2021-11-09 |
Flagship Pioneering Innovations V, Inc. |
Anellovirus compositions and methods of use
|
|
WO2020210805A1
(en)
|
2019-04-11 |
2020-10-15 |
The Johns Hopkins University |
Nanoparticles for drug delivery to brain
|
|
JP2022531201A
(ja)
|
2019-04-28 |
2022-07-06 |
セレクタ バイオサイエンシーズ インコーポレーテッド |
ウイルス導入ベクターに対する既存の免疫を伴う対象の処置のための方法
|
|
CN114206396A
(zh)
|
2019-05-28 |
2022-03-18 |
西莱克塔生物科技公司 |
用于减弱抗病毒转移载体免疫应答的方法和组合物
|
|
EP3980784A1
(en)
|
2019-06-04 |
2022-04-13 |
Selecta Biosciences, Inc. |
Formulations and doses of pegylated uricase
|
|
US20220243211A1
(en)
|
2019-06-21 |
2022-08-04 |
Yale University |
Peptide nucleic acid compositions with modified hoogsteen binding segments and methods of use thereof
|
|
WO2020257779A1
(en)
|
2019-06-21 |
2020-12-24 |
Yale University |
Hydroxymethyl-modified gamma-pna compositions and methods of use thereof
|
|
CN110221081B
(zh)
*
|
2019-06-26 |
2023-01-24 |
上海执诚生物科技有限公司 |
视黄醇结合蛋白胶乳试剂r2及其制备方法和试剂盒
|
|
EP3996511A4
(en)
*
|
2019-07-11 |
2023-09-13 |
Newleaf Symbiotics, Inc. |
MICROBIAL COMPOSITIONS
|
|
US12496357B2
(en)
|
2019-07-31 |
2025-12-16 |
Yale University |
Compositions and methods for treating sickle cell disease
|
|
US20220333132A1
(en)
|
2019-09-03 |
2022-10-20 |
Sana Blotechnology, Inc. |
Cd24-associated particles and related methods and uses thereof
|
|
WO2021061648A1
(en)
|
2019-09-23 |
2021-04-01 |
Massachusetts Institute Of Technology |
Methods and compositions for stimulation of endogenous t cell responses
|
|
EP4048269A1
(en)
|
2019-10-21 |
2022-08-31 |
Selecta Biosciences, Inc. |
Methods and compositions for treating liver diseases and disorders
|
|
CN118384281A
(zh)
|
2019-11-08 |
2024-07-26 |
西莱克塔生物科技公司 |
聚乙二醇化尿酸酶的制剂和剂量
|
|
EP4106828A1
(en)
*
|
2020-02-21 |
2022-12-28 |
GIE Medical, Inc. |
Polymer-encapsulated drug particles
|
|
CA3173734A1
(en)
|
2020-02-26 |
2021-09-02 |
Selecta Biosciences, Inc. |
Methods and compositions using synthetic nanocarriers comprising immunosuppressant
|
|
EP4135693A1
(en)
|
2020-04-14 |
2023-02-22 |
Selecta Biosciences, Inc. |
Methods and compositions for inducing autophagy
|
|
KR20230002873A
(ko)
|
2020-06-05 |
2023-01-05 |
쿡 메디컬 테크놀러지스 엘엘씨 |
치료제 전달을 위한 의료용 스코프
|
|
WO2021255441A1
(en)
*
|
2020-06-16 |
2021-12-23 |
Oxford University Innovation Limited |
Biodegradable multi-cavity microparticles and their use in treatment
|
|
US20230321251A1
(en)
|
2020-09-04 |
2023-10-12 |
Osaka University |
Liposome formulation containing antibacterial agent
|
|
WO2022084929A1
(en)
*
|
2020-10-23 |
2022-04-28 |
Universita' Degli Studi Di Modena E Reggio Emilia |
Nanoparticles for transport across the blood-brain barrier
|
|
WO2022098901A1
(en)
|
2020-11-04 |
2022-05-12 |
Selecta Biosciences, Inc. |
Compositions for reducing immune responses against immunoglobulin proteases
|
|
WO2022150335A1
(en)
|
2021-01-05 |
2022-07-14 |
Selecta Biosciences, Inc. |
Viral vector dosing protocols
|
|
IL306006A
(en)
|
2021-03-19 |
2023-11-01 |
Trained Therapeutix Discovery Inc |
Compounds for controlling trained immunity, and methods of use thereof
|
|
BR112023020597A2
(pt)
|
2021-04-09 |
2023-12-12 |
Selecta Biosciences Inc |
Nanocarreadores sintéticos que compreendem um imunossupressante em combinação com agonistas do receptor de il-2 de alta afinidade para aumentar a tolerância imune
|
|
EP4329734A4
(en)
|
2021-04-26 |
2025-04-02 |
Celanese EVA Performance Polymers LLC |
Implantable device for the delayed release of a macromolecular drug compound
|
|
WO2022261115A1
(en)
|
2021-06-07 |
2022-12-15 |
Yale University |
Peptide nucleic acids for spatiotemporal control of crispr-cas binding
|
|
WO2023064350A1
(en)
|
2021-10-12 |
2023-04-20 |
Selecta Biosciences, Inc. |
Viral vector dosing protocols
|
|
WO2023064367A1
(en)
|
2021-10-12 |
2023-04-20 |
Selecta Biosciences, Inc. |
Methods and compositions for attenuating anti-viral transfer vector igm responses
|
|
US12201643B2
(en)
|
2021-10-15 |
2025-01-21 |
The Board Of Trustees Of The University Of Illinois |
Mechanochemical dynamic for focal cancer treatment
|
|
WO2023086615A1
(en)
|
2021-11-14 |
2023-05-19 |
Selecta Biosciences, Inc. |
Multiple dosing with viral vectors
|
|
US20230263906A1
(en)
|
2022-01-10 |
2023-08-24 |
Selecta Biosciences, Inc. |
High affinity il-2 receptor agonists and synthetic nanocarrier dose sparing
|
|
US20230357437A1
(en)
|
2022-03-09 |
2023-11-09 |
Selecta Biosciences, Inc. |
Immunosuppressants in combination with anti-igm agents and related dosing
|
|
WO2023172628A1
(en)
|
2022-03-09 |
2023-09-14 |
Selecta Biosciences, Inc. |
Immunosuppressant in combination with high affinity il-2 receptor agonists and related dosing
|
|
WO2023183568A1
(en)
|
2022-03-25 |
2023-09-28 |
Selecta Biosciences, Inc. |
Synthetic nanocarriers comprising an immunosuppressant in combination with high affinity il-2 receptor agonists and anti-igm agents
|
|
US20230381277A1
(en)
|
2022-04-08 |
2023-11-30 |
Selecta Biosciences, Inc. |
High affinity il-2 receptor agonists and immunosuppressants to enhance immune tolerance
|
|
CA3264659A1
(en)
|
2022-08-11 |
2024-02-15 |
Cartesian Therapeutics, Inc. |
COMPOSITIONS AND PROCESSES ASSOCIATED WITH IMMUNOGLOBULIN PROTEASES AND FUSION THEREOF
|
|
US12496429B2
(en)
|
2022-10-18 |
2025-12-16 |
Cook Medical Technologies Llc |
Systems and methods for delivering pressurized fluid to a target site alone or in conjunction with therapeutic agents
|
|
WO2024107889A1
(en)
|
2022-11-15 |
2024-05-23 |
Selecta Biosciences, Inc. |
Compositions and methods for treating primary biliary cholangitis
|
|
WO2024229432A1
(en)
|
2023-05-03 |
2024-11-07 |
Cartesian Therapeutics, Inc. |
Synthetic nanocarriers comprising an immunosuppressant in combination with high affinity il-2 receptor agonists to enhance immune tolerance
|
|
WO2024229370A1
(en)
|
2023-05-03 |
2024-11-07 |
Cartesian Therapeutics, Inc. |
Compositions and methods for treating gvhd
|
|
WO2024229350A1
(en)
|
2023-05-03 |
2024-11-07 |
Cartesian Therapeutics, Inc. |
Immunosuppressant in combination with high affinity il-2 receptor agonists for diabetes
|
|
WO2024229380A1
(en)
|
2023-05-03 |
2024-11-07 |
Cartesian Therapeutics, Inc. |
Immunosuppressant in combination with high affinity il-2 receptor agonists in autoimmune liver diseases
|
|
GB202307563D0
(en)
|
2023-05-19 |
2023-07-05 |
Univ King Abdullah Sci & Tech |
Methods and compositions
|
|
AU2024279691A1
(en)
|
2023-06-02 |
2026-01-08 |
33 Medical, Inc. |
Compositions for treatment of discogenic pain, and processes for making and using the same
|
|
US20250032644A1
(en)
|
2023-07-25 |
2025-01-30 |
Massachusetts Institute Of Technology |
Compositions and methods for treating fan1 associated trinucleotide repeat expansion disorders
|